HRES1285FEDERALin_committee

House resolution calls for federal abortion medication policy to be based on scientific evidence

Original title: Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.

May 14, 2026

reproductive health mifepristone federal policy science-based policy

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Where This Stands

Introduced

Committee

Floor Vote

Passed

Currently in_committee. The next step in the legislative lifecycle is Floor Vote.

Last action

Referred to the House Committee on Energy and Commerce.May 14, 2026

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

The Frame

What this does

This measure establishes a formal congressional stance on the regulatory standards for medication abortion, which influences the ongoing national debate regarding access to reproductive healthcare services.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

healthcare providers

Providers who administer or prescribe medication abortion are affected by the regulatory standards and policies discussed in the resolution.

United States residents

Residents seeking access to medication abortion services are affected by the federal policies and laws addressed by this resolution.

What changed

Current stage: in_committee.

What's next

Floor Vote.

Summary

This resolution expresses the formal position of the House of Representatives that federal law and policy regarding should be guided by scientific evidence. It asserts that over 25 years of data demonstrate the safety and effectiveness of the medication.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Why It Matters

Frequently Asked Questions

Does this resolution change current laws regarding abortion medication?

No. This is a '' resolution, which expresses the opinion of the chamber but does not create new binding law or change existing regulations.

What is the purpose of this document?

It serves as a formal statement by the House of Representatives advocating that future policies and laws concerning medication abortion should be grounded in scientific evidence.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Legislative focus on scientific evidence

The resolution explicitly frames the debate over medication abortion access as a matter of scientific evidence-based policy rather than purely legal or moral interpretation.

mifepristone House of Representatives

Connected Entities

organizationHouse Committee on Energy and Commerce“The committee to which the resolution was referred.”Map →

organizationHouse of Representatives“The legislative body issuing the resolution.”Map →

othermifepristone“The medication addressed by the resolution.”Map →

Analysis Score

0–100

Significance65
How much this matters to a regular citizen
Controversy85
Intensity of disagreement among stakeholders
Entertainment10
Compellingness for a non-policy-wonk reader
Buzz40
Current news / social attention level

Publisher tools